Aldevron expands antibody development facility in Freiburg, Germany
Aldevron, a US-based contract development and manufacturing organisation (CDMO), has unveiled plans to expand its antibody development facility located in Freiburg, Germany. The Freiburg site, which houses the GENOVAC antibody development platform, has been a significant part of Aldevron’s operations since 2004, marking the company’s second site. The expansion is driven by increasing demand and […]